Patents by Inventor Cuiying Zhang

Cuiying Zhang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240148903
    Abstract: Provided is a dual recombinant viral vector system for expressing, in a cell, a polypeptide molecule which is composed of two different peptide chains and has an antigen binding activity, wherein the first chain is expressed using a first viral vector, the second chain is expressed using a second viral vector, and the first and second chains can be assembled, after being expressed in a cell, into the polypeptide molecule which has an antigen binding activity. Further provided are a dual plasmid system for the production of the dual recombinant viral vector system, a host cell containing the dual recombinant viral vector system, a pharmaceutical composition, and the use of and the method for delivering the polypeptide molecule to a subject by using the dual recombinant viral vector system.
    Type: Application
    Filed: March 3, 2022
    Publication date: May 9, 2024
    Applicant: Nanjing GenScript Biotech Co., Ltd.
    Inventors: Weiming WANG, Xian ZHANG, Yanling MI, Zhongdao LI, Cuiying SHAO
  • Publication number: 20230212488
    Abstract: The present invention provides a Saccharomyces uvarum strain capable of low production of higher alcohols and strong degradation of malic acid. After the wine using Saccharomyces uvarum recombinant strain of the present invention is fermented for 5 days, with other fermentation properties unaffected, the content of isobutanol, isoamyl alcohol and phenethyl alcohol in the wine is 28.18 mg/L, 171.76 mg/L and 13.60 mg/L respectively, which is reduced by 20.28%, 14.77% and 11.26% compared with the starting strain, the total content of main higher alcohols (n-propanol, isobutanol, isoamyl alcohol and phenethyl alcohol) is reduced by 12.97%, and the content of malic acid is reduced to 1.13 g/L after fermentation, which greatly shortens the fermentation period, overcomes the influence of lactic acid bacteria fermentation in the ordinary fermentation process and unpleasant flavor caused by higher content of higher alcohols.
    Type: Application
    Filed: October 1, 2020
    Publication date: July 6, 2023
    Inventors: Cuiying ZHANG, Tong Li, Ping Li, Dongguang Xiao, Xuewu Guo, Liangcai Lin, Yefu Chen, Aiqun Yu
  • Publication number: 20190054024
    Abstract: A solid pharmaceutical dosage form having drug-loaded particles and methods of making.
    Type: Application
    Filed: August 16, 2017
    Publication date: February 21, 2019
    Applicants: HUMANWELL PHARMACEUTICAL US, Inc., YICHANG HUMANWELL PHARMACEUTICAL CO., LTD.
    Inventors: Jun Yang, Yunqi Wu, Dunxi Chen, Cuiying Zhang, Yuping Yang, Longmei Qu, Lie Li, Jie Li, Wentao Du, Yigang Fu